We are pleased to announce that the manuscript for the clinical trial, "Pemetrexed (Alimta) in Patients with Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study (LUN04-78)”, has been published in the Journal of Thoracic Oncology.
Abstract
Article in pdf
Complete Citation:
Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White W, Stover D, Yu M, Hanna N. Pemetrexed (Alimta) in second line and beyond small cell lung cancer (SCLC): a Hoosier Oncology Group Phase II study. J Thorac Oncol 2009;4(1):93-96.